Vivo Surgical Private Limited

Vivo Surgical is a medical technology developer and manufacturer specializing in innovative surgical and endoscopic devices. The company's primary product portfolio includes three proprietary technologies: ENLYT®, a portable flexible endoscope system for screening and diagnostic imaging applications; KLARO®, an in vivo surgical lighting device designed to overcome limitations of conventional surgical illumination; and ERES™, a minimally-invasive surgical robotic system that integrates with existing conventional endoscopes (currently in development). These devices target unmet clinical needs in hospital and out-of-hospital settings, emphasizing safety, efficiency, and improved clinical outcomes. Vivo Surgical holds regulatory approvals including FDA clearance and CE mark certification, along with ISO 13485 quality management system certification. The company collaborates with leading health systems and academic research institutions globally. Vivo Surgical has received recognition including selection as a WIPO Global Awards 2024 winner (from 660+ companies across 107 countries) and finalist status in the MedTech Innovator Asia Pacific 2023 competition, reflecting strong intellectual property foundations and innovation credentials.